These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8177328)

  • 21. Merck joins the biotech game.
    Bethencourt V
    Nat Biotechnol; 2009 Feb; 27(2):104. PubMed ID: 19204669
    [No Abstract]   [Full Text] [Related]  

  • 22. The quiet revolution.
    Nat Biotechnol; 2003 Jul; 21(7):715. PubMed ID: 12833072
    [No Abstract]   [Full Text] [Related]  

  • 23. The further evolution of biotech.
    Nagle T; Berg C; Nassr R; Pang K
    Nat Rev Drug Discov; 2003 Jan; 2(1):75-9. PubMed ID: 12509762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Greenovation biotech GmbH.
    Arzneimittelforschung; 2008; 58(1):48-9. PubMed ID: 18368951
    [No Abstract]   [Full Text] [Related]  

  • 25. Biotech takes aim at large anti-estrogen markets.
    Hollmer M
    Nat Biotechnol; 2006 Dec; 24(12):1455-6. PubMed ID: 17160027
    [No Abstract]   [Full Text] [Related]  

  • 26. Overcoming the challenges in the pharma/biotech industry.
    Graul AI; Prous JR
    Drug News Perspect; 2007; 20(1):57-68. PubMed ID: 17332900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Today's biotech industry in India.
    Suresh N
    Biotechnol J; 2009 Mar; 4(3):291-4. PubMed ID: 19296434
    [No Abstract]   [Full Text] [Related]  

  • 28. Overcoming the obstacles in the pharma/biotech industry: 2008 update.
    Graul AI; Revel L; Rosa E; Cruces E
    Drug News Perspect; 2009; 22(1):39-51. PubMed ID: 19209298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The development of China's medical biotech industry needs to be driven by innovation.
    Yu Z; Dai Y
    Biotechnol J; 2006 Nov; 1(11):1253-7. PubMed ID: 17068752
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Overcoming further challenges in the pharma/biotech industry: 2007 update.
    Graul AI; Cruces E; Revel L; Serradell N; Rosa E
    Drug News Perspect; 2008; 21(1):44-58. PubMed ID: 18301809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Monoclonal antibody successes in the clinic.
    Reichert JM; Rosensweig CJ; Faden LB; Dewitz MC
    Nat Biotechnol; 2005 Sep; 23(9):1073-8. PubMed ID: 16151394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New law to boost French biotech industry.
    Louët S
    Nat Biotechnol; 1999 Nov; 17(11):1055. PubMed ID: 10545900
    [No Abstract]   [Full Text] [Related]  

  • 33. Biotech patenting slows in 2004.
    Lawrence S
    Nat Biotechnol; 2005 Oct; 23(10):1198. PubMed ID: 16211048
    [No Abstract]   [Full Text] [Related]  

  • 34. Unlocking the money-making potential of RNAi.
    Howard K
    Nat Biotechnol; 2003 Dec; 21(12):1441-6. PubMed ID: 14647324
    [No Abstract]   [Full Text] [Related]  

  • 35. Partnership between small biotech and big pharma.
    Wiederrecht GJ; Hill RG; Beer MS
    IDrugs; 2006 Aug; 9(8):560-4. PubMed ID: 16871465
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biotech acquisitions by big pharma: why and what is next.
    Malik NN
    Drug Discov Today; 2009 Sep; 14(17-18):818-21. PubMed ID: 19584004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proposed changes to patent code loom over biotech industry.
    Coombs A
    Nat Biotechnol; 2007 Dec; 25(12):1333-4. PubMed ID: 18066010
    [No Abstract]   [Full Text] [Related]  

  • 38. [The advances of gene therapy in this quarter century].
    Ito Y; Niitsu Y
    Gan To Kagaku Ryoho; 1999 Jun; 26 Suppl 1():51-9. PubMed ID: 10410659
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Biotech bonanza.
    Stipp D
    Fortune; 1999 Nov; 140(9):333-4. PubMed ID: 10623111
    [No Abstract]   [Full Text] [Related]  

  • 40. Swooping for biotech.
    Wadman M
    Nature; 2005 Sep; 437(7058):475. PubMed ID: 16177760
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.